Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-778-7 | CAS number: 70693-62-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1980-09-12 - 1980-12-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Only male rats were used in this investigation. This is not considered to have comprised the study results as in a comparable investigation performed with Virkon S dust in male and female rats of the same strain and source, male rats were demonstrated to be slightly more sensitive than female rats (please refer to the Endpoint summary record Sect. 7.2.2; Doc. No. 528-002). Thus, the inhalation study reliably reflects and does not underestimate the acute inhalation toxicity potential of KMPS triple salt dust.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 980
- Report date:
- 1980
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPP 81-3 (Acute inhalation toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- The 4-hour LC50 of KMPS triple salt dust was determined in male rats. Groups of 10 male rats were exposed to atmospheres of KMPS triple salt dust for single 4-hour periods. The concentrations ranged from 1.5 to 5.0 mg/L, higher atmospheric concentrations could not be generated under the given experimental conditions.
- GLP compliance:
- no
- Remarks:
- , GLP was not compulsory at the time of study conduct. In addition, laboratories in the USA are not certified by any governmental agency, but are subject to official inspections.
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Pentapotassium bis(peroxymonosulphate) bis(sulphate)
- EC Number:
- 274-778-7
- EC Name:
- Pentapotassium bis(peroxymonosulphate) bis(sulphate)
- Cas Number:
- 70693-62-8
- Molecular formula:
- H3K5O18S4
- IUPAC Name:
- pentapotassium bis((hydroperoxysulfonyl)oxidanide) hydrogen sulfate sulfate
- Test material form:
- solid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Not indicated; rats used at Haskell laboratories were acquired from Charles River Laboratories Inc., Raleigh, North Carolina; U.S.A
- Age at study initiation: 8 weeks
- Weight at study initiation: 228 – 298 g
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- head only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
A dust aerosol of Oxone® (Potassium Peroxymonosulfate/KMPS triple salt) was generated with a 3-stage glass generator composed of dust reservoir, cyclone generator, and elutriator. A stirring rod with plastic paddles agitated the dust in the first 2 stages. Air introduced at the reservoir carried dust particles up to the generator and elutriator. Additional houseline air swept airborne dust from the elutriator stage into the chamber
VEHICLE
- Composition of vehicle: dilution with clean air (“houseline air”) only
TEST ATMOSPHERE
- Particle size distribution: The mass median aerodynamic diameter (MMAD) of the dust generated ranged from 1.7 to 4.0 µm (please refer to table 1, presented under "Any other information on materials and methods incl. tables"). - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 1.5, 3.9, 4.2, 5.0 mg/L (higher atmospheric concentrations could not be generated under the conditions used in the study)
Please refer to table 1, presented under “Any other information on materials and methods incl. tables”. - No. of animals per sex per dose:
- 10 animals (males) per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days post-observation
-Examinations performed:
* Rats were quarantined in pairs, in stainless-steel wire mesh cages for 1 week prior to use. During this period, rats were weighed and observed for normal weight gain and overt manifestations of disease. Food and water were provided ad libitum.
* During exposure, all rats were observed and clinical signs noted.
* Following exposure, rats were weighed and observed daily (excluding weekends) for a 14-day observation period. - Statistics:
- In the absence of any deaths occurring at any exposure levels, a statistical method was not required for the determination of acute inhalation LC50.
Results and discussion
- Preliminary study:
- not indicated
Effect levels
- Key result
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 5 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: no deaths occured
- Mortality:
- No deaths were reported at any exposure level during exposure and during the 14-day observation period.
Please refer to the table presented under “Remarks on results including tables and figures”. - Clinical signs:
- other: During exposure: In all exposures animals exhibited reduced response to sound and moderate to severe, ocular and nasal discharge increasing with concentration. Rats exposed at 1.5 mg/L exhibited moderate lung nouse immediately post exposure. This was not
- Body weight:
- not indicated
- Gross pathology:
- No pathological findings reported.
- Other findings:
- One rat at the highest exposure level of 5.0 mg/L was injured upon removal from the wire mesh restrainer. It was subsequently sacrificed.
Any other information on results incl. tables
Mortality
- | Mean Atmospheric Concentration | Mortality | Time of death |
Male rats | 1.5 | 0/10 | - |
- | 3.9 | 0/10 | - |
- | 4.2 | 0/10 | - |
- | 5.0 | 0/9* | - |
*: One rat was injured upon removal from the wire mesh restrainer. It was subsequently sacrificed
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The study and the conclusions which are drawn from it fulfill the quality criteria (validity, reliability, repeatability). When male Crl:CD rats were exposed head-only for a single 4-hour exposure period towards Oxone® (KMPS triple salt) dust at particle sizes lying well within the respirable range for rats, no deaths occurred up to and including the highest exposure level of 5.0 mg/L tested. Thus, Oxone (KMPS triple salt) does not have to be classified and labelled with respect to acute inhalation toxicity.
- Executive summary:
Materials and methods
The purpose of this investigation was to determine the 4-hour LC50 of Oxone ® (KMPS triple salt) dust in male Crl:CD rats.
Groups of 10 male Crl:CD rats were exposed head-only for a single 4-hour period to dust atmospheres of KMPS triple salt at concentrations of 1.5, 3.9, 4.2 and 5.0 mg/L. Higher atmospheric concentrations could not be generated under these conditions. Except during exposure, rats were housed in pairs, in stainless-steel wire mesh cages. Food and water was provided ad libitum. Rats were quarantined under these conditions for 1 week prior to use. During this period, rats were weighed and observed for normal weight gain and overt manifestations of disease. During exposure, all rats were observed and clinical signs noted. Following exposure, rats were weighed and observed daily (excluding weekends) for a 14-day observation period.
Dust atmospheres were generated with a 3-stage glass generator. Chamber concentrations were gravimetrically verified at 30 min intervals. Particle size measurements were performed once during each exposure.
Results and discussion
A single 4-hour head-only exposure of male rats to chamber concentrations of 1.5, 3.9, 4.2 and 5.0 mg/L caused no mortalities during exposure and the following 14-day post-observation period. During exposure, clinical signs were characterised by moderate to severe ocular and nasal discharge increasing with concentration. Lung noise was reported for the low exposure level only. Slight to severe weight loss during days 1 through 4 and alopecia around the eyes, cloudy eyes as well as severe discharge from eyes and nose was evident at the three highest exposure levels. Weight gain returned to normal during the remainder of the observation period at these exposure levels.
An LC50 could not be determined since no deaths occurred at any exposure concentration.
The MMAD of the dust was determined to be 1.7 to 4.0 µm. Thus, the MMAD was well within the respirable range for rats at all exposure levels.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.